Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Post by lovemulaon Mar 20, 2019 8:01pm

70 Views

Post# 29514217

PP

It so funny that nobody is talking about PP being closed so soon, a week from tomorrow. Maybe it is big coincidence that on that very same day the presentation in Atlanta will start. I really think that something is about to happen.We are supposed to get some sort of news in regards to latest tests with Keytruda. After all it is end of the quarter. A lot of people have been accumulating a lot of shares as of late including me. I think sky is the limit for Briacell.Then again I have been wrong before,but I strongly belive that we have something special going on. JMHO. Good luck to all

Bullboard Posts

FLYHT and WestJet partner on weather forecasting